Troy Schurr, Chief Biopharma Business Officer

Mr. Schurr brings over two decades of leadership experience in commercial oncology across the diagnostic and biotech industries. In his current role, Mr. Schurr leads the company’s collaborations with biotech and pharmaceutical partners. He is responsible for advancing Foundation Medicine’s mission by enabling its collaborators to rapidly bring novel, practice-changing therapies to patients. His team supports partners in early clinical discovery, all the way through to the global approval of companion diagnostics for therapeutics. These partnership efforts also include providing insights from the company’s extensive database of genomic information.